• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    8/30/23 1:18:58 PM ET
    $AKTS
    $ATXI
    $AULT
    $AWIN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AKTS alert in real time by email

     

    On Wednesday, 59 companies achieved new lows for the year.

    Interesting Points From Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Dollar Tree (NASDAQ:DLTR).
    • The company with the smallest market cap to set a new 52-week low was SenesTech (NASDAQ:SNES).
    • Outlook Therapeutics (NASDAQ:OTLK)'s stock fell the most, as it traded down 84.34% to reach a new 52-week low.
    • Dollar Tree (NASDAQ:DLTR)'s shares had the biggest turnaround, impressively rebounding 0.05% after reaching a new 52-week low.

    Here are all the stocks that set new 52-week lows on Wednesday:

    • Dollar Tree (NASDAQ:DLTR) shares moved up 0.05% on Wednesday to hit a new 52-week low of $122.00, drifting up 0.05%.
    • Hain Celestial Group (NASDAQ:HAIN) shares made a new 52-week low of $10.93 on Wednesday. The stock was up 0.32% for the day.
    • SIGNA Sports United (NYSE:SSU) shares set a new yearly low of $1.23 this morning. The stock was down 6.06% on the session.
    • Ioneer (NASDAQ:IONR) shares hit a yearly low of $6.21. The stock was down 2.59% on the session.
    • Vanda Pharma (NASDAQ:VNDA) stock hit a yearly low of $5.26. The stock was down 3.83% for the day.
    • noco-noco (NASDAQ:NCNC) stock hit a new 52-week low of $1.62. The stock was down 13.05% on the session.
    • Karyopharm Therapeutics (NASDAQ:KPTI) stock hit a new 52-week low of $1.33. The stock was up 1.84% on the session.
    • Satellogic (NASDAQ:SATL) stock set a new 52-week low of $1.51 on Wednesday, moving up 1.97%.
    • Faraday Future (NASDAQ:FFIE) shares were down 12.68% for the day, having made a 52-week low of $7.18.
    • Radcom (NASDAQ:RDCM) stock set a new 52-week low of $8.56 on Wednesday, moving up 1.24%.
    • Hawthorn Bancshares (NASDAQ:HWBK) shares were down 0.71% for the day, having made a 52-week low of $16.50.
    • Akoustis Technologies (NASDAQ:AKTS) shares hit a yearly low of $1.53. The stock was down 0.93% on the session.
    • Electrovaya (NASDAQ:ELVA) shares set a new yearly low of $3.18 this morning. The stock was down 3.32% on the session.
    • Complete Solaria (NASDAQ:CSLR) stock drifted down 5.6% on Wednesday morning to hit a new 52-week low of $2.13.
    • Outlook Therapeutics (NASDAQ:OTLK) shares made a new 52-week low of $0.21 on Wednesday. The stock was down 84.34% for the day.
    • Marketwise (NASDAQ:MKTW) shares set a new yearly low of $1.24 this morning. The stock was up 0.78% on the session.
    • SEALSQ (NASDAQ:LAES) shares set a new 52-week low of $5.00. The stock traded down 14.67%.
    • BYND Cannasoft Enterprise (NASDAQ:BCAN) shares made a new 52-week low of $0.85 on Wednesday. The stock was up 1.38% for the day.
    • Kentucky First Federal (NASDAQ:KFFB) stock dropped to a yearly low on Wednesday of $5.21. Shares traded down 4.58%.
    • TD Hldgs (NASDAQ:GLG) stock set a new 52-week low of $0.20 on Wednesday, moving down 28.45%.
    • Electra Battery Materials (NASDAQ:ELBM) shares set a new 52-week low of $0.65. The stock traded up 0.59%.
    • 22nd Century Group (NASDAQ:XXII) stock hit $1.56 on Wednesday morning, setting a new 52-week low for a change of down 4.71%.
    • USD Partners (NYSE:USDP) shares fell to $0.64 on Wednesday, setting a new 52-week low with a shift of down 1.99%.
    • Fusion Fuel Green (NASDAQ:HTOO) stock broke to a new 52-week low of $1.42 on Wednesday. Shares of the company traded down 16.09%.
    • BM Technologies (AMEX:BMTX) shares hit a yearly low of $1.62. The stock was up 0.61% on the session.
    • AERWINS Technologies (NASDAQ:AWIN) shares fell to $0.19 on Wednesday, setting a new 52-week low with a shift of down 0.9%.
    • Lightning eMotors (NYSE:ZEV) stock hit $1.93 on Wednesday morning, setting a new 52-week low for a change of down 1.05%.
    • Alkaline Water Co (NASDAQ:WTER) shares set a new yearly low of $0.86 this morning. The stock was down 0.13% on the session.
    • Pulmatrix (NASDAQ:PULM) stock hit a new 52-week low of $2.33. The stock was up 2.76% on the session.
    • Avalon Holdings (AMEX:AWX) shares hit a yearly low of $2.16. The stock was down 3.94% on the session.
    • Innovative Eyewear (NASDAQ:LUCY) shares hit a yearly low of $0.58. The stock was down 2.3% on the session.
    • Jaguar Health (NASDAQ:JAGX) shares fell to $0.38 on Wednesday, setting a new 52-week low with a shift of down 0.26%.
    • Avenue Therapeutics (NASDAQ:ATXI) stock drifted down 5.42% on Wednesday morning to hit a new 52-week low of $0.80.
    • Medigus (NASDAQ:MDGS) shares made a new 52-week low of $3.70 on Wednesday. The stock was up 1.41% for the day.
    • Ault Alliance (AMEX:AULT) stock achieved a new 52-week low on Wednesday morning, hitting $1.03 and moving up 0.13%.
    • Ontrak (NASDAQ:OTRK) shares were down 3.54% for the day, having made a 52-week low of $1.04.
    • Biolase (NASDAQ:BIOL) stock hit $4.35 on Wednesday morning, setting a new 52-week low for a change of down 1.97%.
    • Jeffs Brands (NASDAQ:JFBR) stock broke to a new 52-week low of $0.48 on Wednesday. Shares of the company traded down 1.98%.
    • Hallmark Financial Servs (NASDAQ:HALL) stock hit a new 52-week low of $1.95. The stock was up 1.37% on the session.
    • 1847 Holdings (AMEX:EFSH) stock drifted up 0.15% on Wednesday morning to hit a new 52-week low of $0.09.
    • Shineco (NASDAQ:SISI) shares were down 6.78% for the day, having made a 52-week low of $0.13.
    • SenesTech (NASDAQ:SNES) shares moved down 5.09% on Wednesday to hit a new 52-week low of $0.55, drifting down 5.09%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $AKTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKTS
    $ATXI
    $AULT
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    Hain Celestial Group Inc.
    $HAIN
    4/9/2026Outperform → Mkt Perform
    William Blair
    Hain Celestial Group Inc.
    $HAIN
    3/16/2026$0.50Equal Weight → Underweight
    Barclays
    Karyopharm Therapeutics Inc.
    $KPTI
    3/10/2026$28.00Buy
    Rodman & Renshaw
    Aktis Oncology Inc.
    $AKTS
    3/9/2026$30.00Buy
    H.C. Wainwright
    Vanda Pharmaceuticals Inc.
    $VNDA
    3/5/2026$18.00Buy
    Truist
    Dollar Tree Inc.
    $DLTR
    2/27/2026$132.00Buy → Neutral
    Citigroup
    Satellogic Inc.
    $SATL
    2/20/2026$7.00Overweight
    Cantor Fitzgerald
    Satellogic Inc.
    $SATL
    2/18/2026$5.50Outperform
    Northland Capital
    More analyst ratings

    $AKTS
    $ATXI
    $AULT
    $AWIN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 18, 2024 - FDA Roundup: June 18, 2024

    For Immediate Release: June 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for input about patient safety associated with certain medical software functions excluded from the medical device definition. This input will help the FDA develop the 2024 report on the risks and benefits to health of non-devic

    6/18/24 3:16:28 PM ET
    $DLTR
    $AMGN
    Department/Specialty Retail Stores
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for PONVORY issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug PONVORY (SUPPL-6) with active ingredient PONESIMOD has changed to 'Approval' on 06/05/2024. Application Category: NDA, Application Number: 213498, Application Classification: Labeling

    6/17/24 12:07:18 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for PONVORY issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug PONVORY (SUPPL-5) with active ingredient PONESIMOD has changed to 'Approval' on 06/05/2024. Application Category: NDA, Application Number: 213498, Application Classification: Labeling

    6/17/24 12:07:18 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Outlook Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

    ISELIN, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) ("Outlook Therapeutics" or the "Company"), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 16,129,033 shares of its common stock at an offering price of $0.31 per share of common stock. Additionally, in a concurrent private placement, the Company issued unregistered warrants to purchase up to an aggregate of 16,129,033 shares of common stock at an exercise price

    4/23/26 4:05:00 PM ET
    $OTLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Fusion Fuel Appoints Uranium Investor James Passin as Chairman and Appoints Frederico Figueira de Chaves as Chief Executive Officer

    Passin, recently appointed to the Board, brings over two decades of institutional uranium investment expertise to help lead the Company's strategic direction Frederico Figueira de Chaves appointed CEO, bringing deep knowledge of the Company's strategy and operations Dublin, April 23, 2026 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (NASDAQ:HTOO) ("Fusion Fuel" or the "Company"), a leading provider of full-service energy engineering, advisory, and utility solutions, today announced changes to its Board of Directors (the "Board") and senior management. James Passin, who was recently appointed to the Board, has been appointed Chairman of the Board, and Frederico Figueira de Chaves has been ap

    4/23/26 8:30:00 AM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    Quality Industrial Corp. Announces CEO Transition

    Carsten Kjems Falk Appointed Chief Executive Officer SAN FRANCISCO, CA, April 23, 2026 (GLOBE NEWSWIRE) -- Quality Industrial Corp. (the "Company") (OTCID: QIND), an industrial and energy-focused company providing comprehensive solutions for the liquefied petroleum gas ("LPG") industry, today announced the appointment of Carsten Kjems Falk as Chief Executive Officer. Mr. Falk will continue to serve as Chief Financial Officer and a director of the Company. The appointment follows the resignation of John-Paul Backwell as Chief Executive Officer, for personal and health reasons. Mr. Backwell will continue to serve as a director of the Company. Mr. Falk has served as the Company's Interim Ch

    4/23/26 8:00:00 AM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    $AKTS
    $ATXI
    $AULT
    $AWIN
    SEC Filings

    View All

    SEC Form DEFA14A filed by Vanda Pharmaceuticals Inc.

    DEFA14A - Vanda Pharmaceuticals Inc. (0001347178) (Filer)

    4/23/26 4:50:50 PM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Vanda Pharmaceuticals Inc.

    DEF 14A - Vanda Pharmaceuticals Inc. (0001347178) (Filer)

    4/23/26 4:48:32 PM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Outlook Therapeutics Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

    8-K - Outlook Therapeutics, Inc. (0001649989) (Filer)

    4/23/26 4:30:39 PM ET
    $OTLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hain Celestial downgraded by William Blair

    William Blair downgraded Hain Celestial from Outperform to Mkt Perform

    4/9/26 8:32:41 AM ET
    $HAIN
    Packaged Foods
    Consumer Staples

    Hain Celestial downgraded by Barclays with a new price target

    Barclays downgraded Hain Celestial from Equal Weight to Underweight and set a new price target of $0.50

    3/16/26 8:35:18 AM ET
    $HAIN
    Packaged Foods
    Consumer Staples

    Rodman & Renshaw initiated coverage on Karyopharm Therapeutics with a new price target

    Rodman & Renshaw initiated coverage of Karyopharm Therapeutics with a rating of Buy and set a new price target of $28.00

    3/10/26 8:41:07 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Kharsansky Alan

    3 - Satellogic Inc. (0001874315) (Issuer)

    4/22/26 5:35:38 PM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form 4 filed by O'Hara John Charles

    4 - SEALSQ Corp (0001951222) (Issuer)

    4/22/26 4:15:08 PM ET
    $LAES
    Semiconductors
    Technology

    SEC Form 4 filed by Rangwala Reshma

    4 - Karyopharm Therapeutics Inc. (0001503802) (Issuer)

    4/22/26 4:03:38 PM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $330,182 worth of shares (171,034 units at $1.93) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    3/17/26 8:10:19 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $56,667 worth of shares (31,346 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/13/26 5:20:17 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Leadership Updates

    Live Leadership Updates

    View All

    Quality Industrial Corp. Announces CEO Transition

    Carsten Kjems Falk Appointed Chief Executive Officer SAN FRANCISCO, CA, April 23, 2026 (GLOBE NEWSWIRE) -- Quality Industrial Corp. (the "Company") (OTCID: QIND), an industrial and energy-focused company providing comprehensive solutions for the liquefied petroleum gas ("LPG") industry, today announced the appointment of Carsten Kjems Falk as Chief Executive Officer. Mr. Falk will continue to serve as Chief Financial Officer and a director of the Company. The appointment follows the resignation of John-Paul Backwell as Chief Executive Officer, for personal and health reasons. Mr. Backwell will continue to serve as a director of the Company. Mr. Falk has served as the Company's Interim Ch

    4/23/26 8:00:00 AM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    Vanda Pharmaceuticals Appoints Dr. Charles Duncan to its Board of Directors

    WASHINGTON, April 22, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced the appointment of Charles Duncan, Ph.D. to its Board of Directors effective April 22, 2026. Following Dr. Duncan's appointment, Vanda's Board of Directors is now comprised of seven directors, six of whom are independent. Dr. Duncan is a highly experienced and respected leader in the life sciences and biotechnology sector," said Mihael H. Polymeropoulos, M.D., Vanda's President, CEO and Chairman of the Board. "We are excited to welcome him to our strong and independent Boa

    4/22/26 5:13:00 PM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors

    BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the "Company"), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced the appointment of Glenn Gormley, MD, PhD, as an independent director to its Board of Directors and co-chair of the Company's newly established Science and Technology Committee of the Board of Directors. "We are delighted to welcome Glenn to our Board as we continue to make significant progress toward upcoming clinical and corporate milestones," said Matthew Roden, PhD, President a

    4/16/26 8:00:00 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Financials

    Live finance-specific insights

    View All

    Hain Celestial Announces Fiscal 2026 Third Quarter Earnings Results Conference Call and Webcast

    HOBOKEN, N.J., April 20, 2026 (GLOBE NEWSWIRE) -- The Hain Celestial Group, Inc. (NASDAQ:HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, will release its fiscal third quarter financial results before the market opens on Monday, May 11, 2026. The company will host a conference call, which will be webcast, to discuss the results at 8:00 AM ET. The webcast and accompanying presentation will be available under the Investors section of the company's corporate website at www.hain.com. Investors and analysts can access the conference call by dialing (800) 715-9871 or (646) 307-1963 and referencing conference ID: 5099

    4/20/26 4:05:00 PM ET
    $HAIN
    Packaged Foods
    Consumer Staples

    MarketWise, Inc. Reports Preliminary Selected Unaudited First Quarter Results with Paid Subscribers Returning to Growth in First Quarter 2026; Billings Increased Approximately 15% year-over-year to Approximately $81 million; Affirms FY 2026 Guidance, Including Dividend Target to Class A Shareholders of $1.80 per Share

    BALTIMORE, April 13, 2026 (GLOBE NEWSWIRE) -- MarketWise, Inc. (NASDAQ:MKTW) is a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed investors, today reported preliminary selected unaudited financial and operational updates for first quarter 2026 below. Consistent with past practice, we are providing investors with selected information in advance of issuing our first quarter 2026 earnings press release, which we expect to release on May 7, 2026. The selected unaudited results in this press release are preliminary and subject to the Company's normal quarterly accounting procedures and externa

    4/13/26 5:04:37 PM ET
    $MKTW
    Computer Software: Prepackaged Software
    Technology

    22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results

    VLN® Commercial Expansion Drives Continued Shift Toward Higher Margin Proprietary Branded Products Expanding VLN® Store Counts and State Authorizations Increase Availability of Smoking Harm Reduction Products MOCKSVILLE, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced results for the fourth quarter and fiscal year-ended December 31, 2025, and provided an update on recent business highlights. The Company's proprietary low nicotine technology is designed to serve adult smokers who want to change their smoking habits by significantly reduci

    3/26/26 6:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Fusion Fuel Green PLC

    SC 13G/A - Fusion Fuel Green PLC (0001819794) (Subject)

    12/11/24 4:02:05 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    SEC Form SC 13D filed by Fusion Fuel Green PLC

    SC 13D - Fusion Fuel Green PLC (0001819794) (Filed by)

    12/6/24 6:06:39 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    SEC Form SC 13G filed by Fusion Fuel Green PLC

    SC 13G - Fusion Fuel Green PLC (0001819794) (Subject)

    12/3/24 4:00:02 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy